Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  PubMed  Google Scholar 

Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003;21(18):1315–30. https://doi.org/10.1007/BF03262330.

Article  PubMed  Google Scholar 

Jubber I, Ong S, Bukavina L, Black PC, Comperat E, Kamat AM, Kiemeney L, Lawrentschuk N, Lerner SP, Meeks JJ, Moch H, Necchi A, Panebianco V, Sridhar SS, Znaor A, Catto JWF, Cumberbatch MG. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84(2):176–90. https://doi.org/10.1016/j.eururo.2023.03.029.

Article  PubMed  Google Scholar 

Ling S, Brown K, Miksza JK, Howells L, Morrison A, Issa E, Yates T, Khunti K, Davies MJ, Zaccardi F. Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people. Diabetes Care. 2020;43(9):2313–22. https://doi.org/10.2337/dc20-0204.

Article  PubMed  Google Scholar 

Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006;49(12):2819–23. https://doi.org/10.1007/s00125-006-0468-0.

Article  CAS  PubMed  Google Scholar 

Zhu Z, Wang X, Shen Z, Lu Y, Zhong S, Xu C. Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. BMC Cancer. 2013;13:310. https://doi.org/10.1186/1471-2407-13-310.

Article  PubMed  PubMed Central  Google Scholar 

Vicentini M, Ballotari P, Venturelli F, Ottone M, Manicardi V, Gallo M, Greci M, Pinotti M, Pezzarossi A, Giorgi Rossi P. Impact of insulin therapies on cancer incidence in type 1 and type 2 diabetes: a population-based cohort study in Reggio Emilia. Italy Cancers (Basel). 2022. https://doi.org/10.3390/cancers14112719.

Article  PubMed  Google Scholar 

van den Brandt PA, Goldbohm RA, van’t Veer P, Volovics A, Hermus RJ, Sturmans F. A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol. 1990;43(3):285–95. https://doi.org/10.1016/0895-4356(90)90009-e.

Article  PubMed  Google Scholar 

Prentice RL. A case-cohort design for epidemiologic studies and disease prevention trials. Biometrika. 1986;73(1):1–11.

Article  MathSciNet  Google Scholar 

van den Brandt PA, Schouten LJ, Goldbohm RA, Dorant E, Hunen PM. Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol. 1990;19(3):553–8.

Article  PubMed  Google Scholar 

van den Brandt PA, van’t Veer P, Goldbohm RA, Dorant E, Volovics A, Hermus RJ, Sturmans F. A prospective cohort study on dietary fat and the risk of postmenopausal breast cancer. Cancer Res. 1993;53(1):75–82.

PubMed  Google Scholar 

de Kort S, Simons CC, van den Brandt PA, Goldbohm RA, Arts IC, de Bruine AP, Janssen-Heijnen ML, Sanduleanu S, Masclee AA, Weijenberg MP. Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer. Eur J Gastroenterol Hepatol. 2016;28(8):896–903. https://doi.org/10.1097/MEG.0000000000000626.

Article  PubMed  Google Scholar 

van den Brandt PA, Petri H, Dorant E, Goldbohm RA, Van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci. 1991;13(2):91–6. https://doi.org/10.1007/BF01974987.

Article  PubMed  Google Scholar 

Hermans K, Haque S, van den Brandt PA, Loef C, Jansen RLH, Schouten LJ. Type 2 diabetes mellitus and cancer of unknown primary risk: results from the Netherlands Cohort Study. Eur J Cancer Prev. 2022;31(6):600–8. https://doi.org/10.1097/CEJ.0000000000000749.

Article  CAS  PubMed  Google Scholar 

Goldbohm RA, van den Brandt PA, Brants HA, van’t Veer P, Al M, Sturmans F, Hermus RJ. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr. 1994;48(4):253–65.

CAS  PubMed  Google Scholar 

Goldbohm RA, van’t Veer P, van den Brandt PA, van Hof MA, Brants HA, Sturmans F, Hermus RJ. Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr. 1995;49(6):420–9.

CAS  PubMed  Google Scholar 

Nevo-Table. Dutch Food Composition table 1986–1987; Nederlands voedingsstoffenbestand 1986–1987. The Hague: Voorlichtingsbureau voor de Voeding. 1986.

Lin D, Wei L. The robust inference for the Cox proportional hazards model. J Am Stat Assoc. 1989;84(408):1074–8.

Article  MathSciNet  Google Scholar 

Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41.

Article  Google Scholar 

Harding JL, Shaw JE, Peeters A, Cartensen B, Magliano DJ. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care. 2015;38:264–70. Erratum in: Diabetes Care. 2015;38(4):734–5. https://doi.org/10.2337/dc15-er04a

Article  PubMed  Google Scholar 

Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet. 2002;359(9318):1686–9. https://doi.org/10.1016/S0140-6736(02)08594-X.

Article  PubMed  Google Scholar 

Prizment AE, Anderson KE, Yuan JM, Folsom AR. Diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women’s Health Study. Cancer Causes Control. 2013;24(3):603–8. https://doi.org/10.1007/s10552-012-0143-3.

Article  PubMed  PubMed Central  Google Scholar 

Newton CC, Gapstur SM, Campbell PT, Jacobs EJ. Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study. Int J Cancer. 2013;132(9):2186–91. https://doi.org/10.1002/ijc.27878.

Article  CAS  PubMed  Google Scholar 

Lai GY, Park Y, Hartge P, Hollenbeck AR, Freedman ND. The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study. J Clin Endocrinol Metab. 2013;98(3):E497-502. https://doi.org/10.1210/jc.2012-3335.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peila R, Rohan TE. Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study. Cancer Epidemiol Biomarkers Prev. 2020;29(6):1107–19. https://doi.org/10.1158/1055-9965.EPI-19-1623.

Article  CAS  PubMed  Google Scholar 

Li Y, Hendryx MS, Xun P, He K, Shadyab AH, Pan K, Qi L, Luo J. The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women. Cancer Causes Control. 2020;31(5):503–10. https://doi.org/10.1007/s10552-020-01294-0.

Article  PubMed  PubMed Central  Google Scholar 

Pan Y, Lee CY, Lee LM, Wen YC, Huang JY, Yang SF, Hsiao CH. Incidence of bladder cancer in type 2 diabetes mellitus patients: a population-based cohort study. Medicina (Kaunas). 2020. https://doi.org/10.3390/medicina56090441.

Article  PubMed  Google Scholar 

Choi YH, Park YM, Hur KJ, Ha US, Hong SH, Lee JY, Kim SW, Han K, Ko SH, Park YH. Duration of diabetes mellitus and risk of kidney and bladder cancer: a longitudinal nationwide cohort study. Am J Cancer Res. 2022;12(8):4050–61.

PubMed  PubMed Central  Google Scholar 

Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell. 2012;150(6):1223–34. https://doi.org/10.1016/j.cell.2012.07.029.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009;52(9):1766–77. https://doi.org/10.1007/s00125-009-1440-6.

Article  CAS  PubMed  Google Scholar 

Ruiter R, Visser LE, van Herk-Sukel MP, Coebergh JW, Haak HR, Geelhoed-Duijvestijn PH, Straus SM, Herings RM, Stricker BH. Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study. Diabetes Care. 2012;35(1):119–24. https://doi.org/10.2337/dc11-0857.

Article  CAS  PubMed  Google Scholar 

Sondergaard CS, Esquivel PN, Dalamaga M, Magkos F. Use of antihyperglycemic drugs and risk of cancer in patients with diabetes. Curr Oncol Rep. 2023;25(1):29–40. https://doi.org/10.1007/s11912-022-01344-7.

Article  CAS  PubMed  Google Scholar 

Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009;16(4):1103–23. https://doi.org/10.1677/ERC-09-0087.

Article  CAS  PubMed  Google Scholar 

Xu Y, Huo R, Chen X, Yu X. Diabetes mellitus and the risk of bladder cancer: a PRISMA-compliant meta-analysis of cohort studies. Medicine (Baltimore). 2017;96(46):e8588. https://doi.org/10.1097/MD.0000000000008588.

Article  PubMed  Google Scholar 

Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–85. https://doi.org/10.2337/dc10-0666.

Article  PubMed  PubMed Central  Google Scholar 

Song QX, Sun Y, Deng K, Mei JY, Chermansky CJ, Damaser MS. Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction. Nat Rev Urol. 2022;19(10):581–96. https://doi.org/10.1038/s41585-022-00621-1.

Article  PubMed